ritanserin has been researched along with sb 215505 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdel-Raziq, MS; Gabr, MT | 1 |
Blackburn, TP; Holland, V; Kettle, A; Reavill, C; Riley, G | 1 |
2 other study(ies) available for ritanserin and sb 215505
Article | Year |
---|---|
Pharmacophore-based tailoring of biphenyl amide derivatives as selective 5-hydroxytryptamine 2B receptor antagonists.
Topics: | 2018 |
Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist.
Topics: Animals; Binding, Competitive; Catalepsy; Cell Line; Dopamine Antagonists; Fluorobenzenes; Haloperidol; Humans; Indoles; Male; Piperidines; Quinolines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists | 1999 |